NLRP3 rs4378247: What Your Genotype Means
The rs4378247 polymorphism is a single-nucleotide variant situated in the NLRP3 gene region, which encodes a critical sensor protein of the innate immune system. Published immunology research has linked alleles at this locus to differences in inflammatory cytokine signaling, specifically interleukin-13 (IL-13) levels following exposure to environmental allergens such as house dust mites. Evidence regarding this variant's overall impact on asthma and allergic airway inflammation remains limited and represents subtle variations in immune reactivity rather than a direct clinical diagnosis.
What each genotype means
Typical NLRP3 variant profile
This genotype represents the common baseline for this region of the NLRP3 gene. Research into this specific variant is limited, but it has been studied for potential associations with allergic airway inflammation and sensitivity to specific allergens like house dust mites. Because the evidence is limited and often specific to certain populations, this result should not be used to predict personal health outcomes.
This is a common genotype found across many global ancestral populations.
Potential altered inflammatory susceptibility
Carrying one copy of the variant allele may be associated with differences in how the NLRP3 inflammasome responds to environmental triggers, such as house dust mites. Current evidence is limited and primarily derived from specific population studies, meaning the clinical significance for an individual remains uncertain. You should view this as a research-based observation rather than a diagnostic indicator.
This heterozygous genotype is observed at varying frequencies across diverse ancestral groups.
Potential altered inflammatory susceptibility
Carrying two copies of the variant allele has been investigated for links to increased susceptibility to asthma and specific allergic responses in some research cohorts. The evidence remains limited and context-dependent, as these associations may not apply universally to all individuals or populations. This information is for educational purposes and does not constitute a medical diagnosis.
This genotype is present in the general population, though its frequency varies significantly by ancestry.
Genetic Location and Variant Details
The single-nucleotide polymorphism rs4378247 is located on chromosome 1 within the genomic neighborhood of the NLRP3 gene. As indexed in biological repositories such as [dbSNP rs4378247](https://www.ncbi.nlm.nih.gov/snp/rs4378247), this locus represents a common point of natural variation in human populations, primarily presenting as a C or T nucleotide exchange. In typical genomic architecture, non-coding or regulatory variants near innate immunity genes can influence transcriptional efficiency, downstream messenger RNA stability, or interaction with transcription factor binding sites. Unlike high-penetrance coding mutations that cause rare monogenic autoinflammatory conditions—such as cryopyrin-associated periodic syndromes (CAPS)—rs4378247 functions as a common polymorphic variant that subtly shifts baseline regulatory dynamics. Because it sits in a complex immune-regulating gene cluster, scientific curiosity has centered on how subtle variations at this position might affect an individual's susceptibility to widespread inflammatory stimuli.
The Biological Role of the NLRP3 Inflammasome
The NLRP3 gene instructs the production of cryopyrin (also known as NLRP3), a central cytoplasmic pattern recognition receptor belonging to the nucleotide-binding domain and leucine-rich repeat-containing family. When immune cells such as macrophages and dendritic cells encounter cellular distress, environmental particulates, or pathogen-associated molecules, the NLRP3 protein acts as a scaffold to form the multiprotein NLRP3 inflammasome complex. Upon assembly, this complex recruits and activates caspase-1, which processes inactive precursor molecules into the mature pro-inflammatory cytokines interleukin-1 beta (IL-1β) and interleukin-18 (IL-18). In the context of allergic disease, the NLRP3 inflammasome acts at the intersection of innate sensing and adaptive type 2 helper T-cell (Th2) responses. While controlled activation helps maintain protective mucosal barrier integrity, exaggerated signaling can exacerbate tissue eosinophilia, mucus hypersecretion, and chronic allergic airway reactivity.
Published Research on Allergic Susceptibility
Scientific evaluation of rs4378247 has linked the variant to altered immune reactivity during allergen challenges, as noted in studies investigating childhood asthma and environmental hypersensitivity ([Queiroz et al., Cytokine: X](https://pubmed.ncbi.nlm.nih.gov/33015616/)). In laboratory assays evaluating peripheral blood mononuclear cells exposed to extracts of the tropical house dust mite *Blomia tropicalis*, carriers of the C allele exhibited significantly reduced production of interleukin-13 (IL-13)—a canonical type 2 cytokine known to promote airway hyperresponsiveness and allergic inflammation. However, the existing clinical evidence remains categorized as limited. The primary associations have been documented in specialized pediatric cohorts, and overall risk profiles appear to depend heavily on multi-variant interactions across the IL-33 and CASP1 signaling cascades. Broad genome-wide association studies (GWAS) cataloging allergic rhinitis and asthma phenotypes have not firmly established rs4378247 as an isolated, standalone driver of disease, emphasizing the need for replicated studies across diverse populations.
Understanding Context and Practical Application
Learning your rs4378247 genotype provides educational insight into one piece of your innate immune framework, but it is not a diagnostic test. Allergic conditions such as asthma, allergic rhinitis, and house dust mite hypersensitivity are complex, multifactorial traits driven by dozens of small-effect genetic variants interacting with indoor and outdoor environmental exposures. Possessing a genotype linked to lower or higher cytokine production does not mean you are guaranteed immunity from or destined to develop allergies. Readers should not alter prescribed allergy medications, inhalers, or dust mite avoidance measures based on this genetic finding alone. Instead, individuals dealing with persistent respiratory symptoms, atopic eczema, or suspected environmental allergies should consult a board-certified allergist or primary care clinician for formal allergy skin-prick testing, specific IgE blood panels, and personalized treatment plans.
How common is this variant?
The rs4378247 variant is common across multiple ancestral populations, with both C and T alleles frequently observed in global reference panels including the 1000 Genomes Project and gnomAD datasets.
Frequently asked questions
Does having the rs4378247 variant mean I will definitely develop a dust mite allergy?
No. The rs4378247 variant is only associated with modest differences in inflammatory cytokine production in laboratory studies and does not diagnose a clinical allergy. Environmental exposure, barrier health, and hundreds of other genetic factors collectively determine whether an individual develops symptomatic allergies.
Can testing for rs4378247 guide which asthma inhaler or allergy medication I should take?
No, clinical pharmacogenomics guidelines from organizations like CPIC do not include recommendations based on rs4378247. Genotyping at this locus cannot determine drug efficacy or dosage, so any questions regarding allergy or asthma medications should be discussed directly with your healthcare provider.
How does the NLRP3 gene affect the immune system's response to allergens?
NLRP3 encodes a protein that forms the core of the NLRP3 inflammasome, a cellular sensor that activates caspase-1 and triggers the release of inflammatory molecules like IL-1β. When airways encounter airborne particles such as dust mite proteins, inflammasome activation helps coordinate the recruitment of immune cells and the subsequent cascade of allergic inflammation.
Why is the evidence linking rs4378247 to allergies classified as limited?
While targeted studies have found statistically significant associations between rs4378247 and cellular IL-13 production in specific cohorts, large-scale genome-wide association studies (GWAS) have not consistently validated it as a major standalone contributor across global cohorts. Consequently, geneticists consider the current published evidence promising but preliminary.
Sources & further reading
Educational information only, last refreshed 9/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4378247?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29